Invion Reports 79% Disease Control in Phase 1 Skin Cancer Trial
Invion closed Phase 1 recruitment in non-melanoma skin cancer, reporting 79% disease control across 14 patients — an early signal now awaiting full data readout.
Topic
Phase 1 Trial
Topic
Phase 1 Trial
First Human Data on Experimental Eczema Therapy Set for November
First-in-human data on an experimental eczema treatment arrives in November — from healthy volunteers, meaning safety, not effica…